The latest advancements in upper gastrointestinal (GI) cancer treatment include early detection tools, immunotherapy, ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Esophageal cancer (EC) ranks as the eighth most prevalent malignancy globally. China exhibits notably high incidence rates of esophageal cancer within East Asia and worldwide, coupled with one of the ...

In the article that accompanies this editorial, Babiker et al 12 present the data that tumor-treating fields (TTFs) combined with gemcitabine plus nab-paclitaxel improved median overall survival ...